NIH Funding

About the NIH

The Center for Molecular Medicine is supplemented in funds by grants through the National Institutes of Health. The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency. NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery.

More information coming soon!

Grants

COBRE Grant

The Core Facilities are currently supported by the COBRE Grant. The COBRE program seeks to promote the initiation and development or expansion of unique, innovative state-of-the-art biomedical and behavioral research centers at institutions in IDeA-eligible states. Research supported by this program spans the full spectrum of basic and clinical sciences and encompasses all areas of health-related investigation. The NIH recognizes that contributions from institutions in IDeA-eligible states are important and essential in fulfilling the promise of the NIH research agenda. The intent of this FOA is to assist these institutions to implement and use the technologies and other resources needed to conduct state-of-the-art research.

The COBRE program consists of three sequential five-year phases.  Phase 1, which is the focus of this FOA, aims to (1) strengthen an institution's biomedical research infrastructure through the establishment of a thematic multi-disciplinary center and (2) enhance the ability of investigators to compete independently for complementary NIH individual research grants or other external peer-reviewed support.  Phase 2  is intended to strengthen the center through further improvements in research infrastructure and to continue development and support of a critical mass of investigators with shared scientific interests. Phase 3 provides support for maintaining COBRE research cores developed during phases 1 and 2.

See Core Facilities

Rigor and Reproducibility Training

Two of the cornerstones of science advancement are rigor in designing and performing scientific experiments and the ability to reproduce biomedical research findings. The application of rigor ensures robust and unbiased experimental design, methodology, analysis, interpretation, and reporting of results. When a result can be reproduced by multiple scientists, it validates the original results and readiness to progress to the next phase of research. This is especially important for clinical trials in humans, which are built on studies that have demonstrated a particular effect or outcome.

Visit the Rigor and Reproducibility page for information about the efforts underway by NIH to enhance rigor and reproducibility in scientific research.

Learn More

 

No